These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6365535)

  • 1. Progress in immunization against Klebsiella infections.
    Cryz SJ
    Eur J Clin Microbiol; 1983 Dec; 2(6):523-8. PubMed ID: 6365535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
    Cryz SJ; Mortimer P; Cross AS; Fürer E; Germanier R
    Vaccine; 1986 Mar; 4(1):15-20. PubMed ID: 3962447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
    Hussein KE; Bahey-El-Din M; Sheweita SA
    Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in immunization against Pseudomonas aeruginosa and Klebsiella spp.
    Cryz SJ
    Pathol Immunopathol Res; 1987; 6(2):147-52. PubMed ID: 3122194
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae.
    Lundberg U; Senn BM; Schüler W; Meinke A; Hanner M
    Hum Vaccin Immunother; 2013 Mar; 9(3):497-505. PubMed ID: 23250007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress towards the development of Klebsiella vaccines.
    Choi M; Tennant SM; Simon R; Cross AS
    Expert Rev Vaccines; 2019 Jul; 18(7):681-691. PubMed ID: 31250679
    [No Abstract]   [Full Text] [Related]  

  • 7. Klebsiella polysaccharide vaccines.
    Cryz SJ
    Adv Biotechnol Processes; 1990; 13():87-103. PubMed ID: 2185788
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of intravenous immune globulins against Klebsiella.
    Cryz SJ; Cross AS; Fürer E; Chariatte N; Sadoff JC; Germanier R
    J Lab Clin Med; 1986 Sep; 108(3):182-9. PubMed ID: 3746094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
    Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
    Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against fatal Klebsiella pneumoniae sepsis in the squirrel monkey Saimiri sciureus after immunization with a capsular polysaccharide vaccine.
    Postal JM; Gysin J; Crenn Y
    Ann Inst Pasteur Immunol; 1988; 139(4):401-7. PubMed ID: 3048318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.
    Cryz SJ; Mortimer PM; Mansfield V; Germanier R
    J Clin Microbiol; 1986 Apr; 23(4):687-90. PubMed ID: 3517058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization of protective activity in human sera against infection with Klebsiella ozaenae].
    Iwami S
    Nihon Ika Daigaku Zasshi; 1983 Apr; 50(2):264-70. PubMed ID: 6863492
    [No Abstract]   [Full Text] [Related]  

  • 13. Escherichia coli and Klebsiella vaccines and immunotherapy.
    Cross AS; Sadoff JC; Furer E; Cryz SJ
    Infect Dis Clin North Am; 1990 Jun; 4(2):271-82. PubMed ID: 2189000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections.
    Trautmann M; Ruhnke M; Rukavina T; Held TK; Cross AS; Marre R; Whitfield C
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):550-5. PubMed ID: 9302204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma.
    Campbell WN; Hendrix E; Cryz S; Cross AS
    Clin Infect Dis; 1996 Jul; 23(1):179-81. PubMed ID: 8816151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine.
    Cryz SJ; Cross AS; Sadoff GC; Que JU
    Eur J Immunol; 1988 Dec; 18(12):2073-5. PubMed ID: 3220104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats.
    Chhibber S; Rani M; Vanashree Y
    Indian J Exp Biol; 2005 Jan; 43(1):40-5. PubMed ID: 15691064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae.
    Kobayashi SD; DeLeo FR
    Future Microbiol; 2018 Sep; 13(12):1343-1346. PubMed ID: 30256152
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.
    Donta ST; Peduzzi P; Cross AS; Sadoff J; Haakenson C; Cryz SJ; Kauffman C; Bradley S; Gafford G; Elliston D; Beam TR; John JF; Ribner B; Cantey R; Welsh CH; Ellison RT; Young EJ; Hamill RJ; Leaf H; Schein RM; Mulligan M; Johnson C; Abrutyn E; Griffiss JM; Slagle D
    J Infect Dis; 1996 Sep; 174(3):537-43. PubMed ID: 8769611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological cross-reactivity between Enterobacter aerogenes and Klebsiella capsular polysaccharides.
    Cryz SJ; Pitt TL; Ayling-Smith B; Que JU
    Microb Pathog; 1990 Aug; 9(2):127-30. PubMed ID: 2277587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.